Immuron (IMRN) Common Equity (2016 - 2025)

Immuron has reported Common Equity for 10 years, with the latest figure at $80318.3 in Q3 2025.

• For the quarter ending Q3 2025, Common Equity fell 36.8% year-over-year to $80318.3; the trailing twelve-month figure through Sep 2025 stood at $80318.3 (down 36.8% YoY), and the FY2025 full-year result was $80318.3, down 36.8% from the prior year.
• Common Equity for Q3 2025 stood at $80318.3, down from $5.2 million in the prior quarter.
• The five-year high for Common Equity was $18.9 million in Q4 2021, with the low at $80318.3 in Q3 2025.
• Average Common Equity over 5 years is $7.0 million, with a median of $6.0 million recorded in 2024.
• Year-over-year, Common Equity soared 6509.72% in 2021 and slumped 99.25% in 2023.
• Tracing IMRN's Common Equity over 5 years: stood at $18.9 million in 2021, then retreated by 19.28% to $15.2 million in 2022, then tumbled by 99.25% to $114095.9 in 2023, then soared by 5826.24% to $6.8 million in 2024, then sank by 98.81% to $80318.3 in 2025.
• The last three Common Equity figures came in at $80318.3 (Q3 2025), $5.2 million (Q2 2025), and $6.8 million (Q4 2024), per Business Quant data.

Peer Comparison